Prime Medicine (PRME) Change in Accured Expenses (2021 - 2026)

Prime Medicine (PRME) has 6 years of Change in Accured Expenses data on file, last reported at -$4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 32.35% year-over-year to -$4.5 million; the trailing twelve-month figure through Mar 2026 stood at $993000.0 (up 394.66% YoY), and the FY2025 full-year result was -$1.2 million, down 162.94% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$4.5 million, down from $1.6 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $5.9 million in Q3 2024 and bottomed at -$33.3 million in Q1 2022.
• The 5-year median for Change in Accured Expenses is $608000.0 (2023), against an average of -$1.6 million.
• Peak annual rise in Change in Accured Expenses reached 1211.11% in 2025, while the deepest fall reached 118.06% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $4.1 million in 2022, then slumped by 38.53% to $2.5 million in 2023, then plunged by 105.73% to -$144000.0 in 2024, then jumped by 1211.11% to $1.6 million in 2025, then plunged by 381.38% to -$4.5 million in 2026.
• The last three Change in Accured Expenses figures came in at -$4.5 million (Q1 2026), $1.6 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.

Peer Comparison